GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (STU:LSI) » Definitions » Intrinsic Value: Projected FCF

CK Life Sciences International Holdings (STU:LSI) Intrinsic Value: Projected FCF : €0.05 (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-16), CK Life Sciences International Holdings's Intrinsic Value: Projected FCF is €0.05. The stock price of CK Life Sciences International Holdings is €0.0505. Therefore, CK Life Sciences International Holdings's Price-to-Intrinsic-Value-Projected-FCF of today is 1.0.

The historical rank and industry rank for CK Life Sciences International Holdings's Intrinsic Value: Projected FCF or its related term are showing as below:

STU:LSI' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.77   Med: 1.46   Max: 1.93
Current: 1.01

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of CK Life Sciences International Holdings was 1.93. The lowest was 0.77. And the median was 1.46.

STU:LSI's Price-to-Projected-FCF is ranked better than
85.24% of 210 companies
in the Biotechnology industry
Industry Median: 2.48 vs STU:LSI: 1.01

CK Life Sciences International Holdings Intrinsic Value: Projected FCF Historical Data

The historical data trend for CK Life Sciences International Holdings's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Intrinsic Value: Projected FCF Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.05 0.05 0.05 0.05

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 - 0.05 - 0.05

Competitive Comparison of CK Life Sciences International Holdings's Intrinsic Value: Projected FCF

For the Biotechnology subindustry, CK Life Sciences International Holdings's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's Price-to-Projected-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Price-to-Projected-FCF falls into.



CK Life Sciences International Holdings Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get CK Life Sciences International Holdings's Free Cash Flow(6 year avg) = €14.60.

CK Life Sciences International Holdings's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*14.595428571429+491.888*0.8)/9611.073
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CK Life Sciences International Holdings  (STU:LSI) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

CK Life Sciences International Holdings's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.0505/0.055401099512384
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CK Life Sciences International Holdings Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (STU:LSI) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (STU:LSI) Headlines

From GuruFocus

AEW CAPITAL MANAGEMENT L P Buys 3, Sells 2 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-07-2023

Life Storage Inc (LSI) COO Edward F Killeen Sold $2.1 million of Shares

By GuruFocus Research GuruFocus Editor 12-08-2021

Life Storage Inc (LSI) CEO Joseph Saffire Sold $585,560 of Shares

By GuruFocus Research GuruFocus Editor 12-21-2021

Life Storage Inc (LSI) CFO Andrew J Gregoire Sold $1 million of Shares

By GuruFocus Research GuruFocus Editor 11-30-2021

Life Storage, Inc. Raises Quarterly Common Stock Dividend by 8%

By Business Wire Business Wire 07-05-2022